38 results
8-K
EX-99.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
years from the date of issuance. The closing of the offering is expected to occur on or about February 6, 2024, subject to the satisfaction of customary … in this press release are forward-looking statements, including statements concerning the completion of the offering, the satisfaction of customary closing
S-3
EX-4.5
NEXI
Neximmune Inc
9 Mar 22
Shelf registration
5:14pm
3.01 Redemption
SECTION 3.02 Notice of Redemption
SECTION 3.03 Payment Upon Redemption
SECTION 3.04 Sinking Fund
SECTION 3.05 Satisfaction of Sinking … 10.02 Successor Entity Substituted
SECTION 10.03 Evidence of Consolidation, Etc. to Trustee
ARTICLE XI SATISFACTION AND DISCHARGE
SECTION 11.01
S-3
EX-4.6
NEXI
Neximmune Inc
9 Mar 22
Shelf registration
5:14pm
SECTION 3.04
Sinking Fund
SECTION 3.05
Satisfaction of Sinking Fund Payments with Securities
SECTION 3.06
Redemption of Securities for Sinking Fund …
ARTICLE XI
SATISFACTION AND DISCHARGE
SECTION 11.01
Satisfaction and Discharge of Indenture
SECTION 11.02
Discharge of Obligations
SECTION 11.03
8-K
EX-5.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
and Restated Certificate of Incorporation and Restated Bylaws, as currently in effect, and (C) the originals or copies certified to our satisfaction
DRS
EX-3.1
NEXI
Neximmune Inc
14 Dec 20
Draft registration statement
12:00am
of the consideration payable to the stockholders of the Corporation is payable only upon satisfaction of contingencies (the “Additional Consideration … payable to the stockholders of the Corporation upon satisfaction of such contingencies shall be allocated among the holders of capital stock
S-1
EX-3.1.1
umcawgjszvim2
19 Jan 21
IPO registration
4:38pm
DRS/A
EX-3.1
7b4yt1p k4v94r
15 Jan 21
Draft registration statement (amended)
12:00am
8-K
cjw8ti4sj 3e5u
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
S-1
EX-10.12
rjpo wtgp
19 Jan 21
IPO registration
4:38pm
DRS/A
EX-10.12
jatr2 73k0
15 Jan 21
Draft registration statement (amended)
12:00am
8-K
EX-10.1
wof68oz espgk2155
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
8-K
EX-4.1
bfdste
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
S-1/A
EX-10.4.2
72z saolfjevqcng
8 Feb 21
IPO registration (amended)
7:29am
8-K
EX-4.2
udqvi2rm6 ic
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
8-K
EX-4.3
j03gbnsw7v8a38muoxqf
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
S-1/A
EX-10.2.1
nfl lnjwd2x53
8 Feb 21
IPO registration (amended)
7:29am